Sanofi Ends Marketing Deal With Developer of Inhaled Insulin by ANDREW POLLACK

By ANDREW POLLACK

The insulin, called Afrezza, has had poor sales since being approved by the Food and Drug Administration in 2014.

Published: January 6, 2016 at 12:00AM

from NYT Business Day http://ift.tt/1Rfh3uG

from WordPress http://ift.tt/1IOHhBl
via Hadi Aboukhater